GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
124 hedge funds and large institutions have $1.01B invested in Genomic Health, Inc. in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 59 increasing their positions, 37 reducing their positions, and 6 closing their positions.
Holders
124
Holders Change
–
Holders Change %
0%
% of All Funds
3.1%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
7
Increased
59
Reduced
37
Closed
6
Calls
$401K
Puts
–
Net Calls
+$401K
Net Calls Change
+$26K
Top Buyers
| 1 |
1
Invesco
Atlanta,
Georgia
|
$6.61M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$54.4M |
| 3 |
PAM
3
Panagora Asset Management
Boston,
Massachusetts
|
$5.33M |
| 4 |
4
Bank of America
Charlotte,
North Carolina
|
$3.14M |
| 5 |
5
Renaissance Technologies
New York
|
$26.5M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MWNA
126
Marshall Wace North America
New York
| – | -$845K | -27,248 | Closed |
|
|
SCM
127
Stonebridge Capital Management
Los Angeles,
California
| – | -$259K | -8,205 | Closed |
|
128
Fifth Third Bancorp
Cincinnati,
Ohio
| – | -$2K | -50 | Closed |
|
|
FANJ
129
Financial Architects (New Jersey)
Marlton,
New Jersey
| – | -$1K | -34 | Closed |
|